These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2586634

  • 1. Cholinomimetic activities of minaprine.
    Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):411-8. PubMed ID: 2586634
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.
    Schumacher C, Steinberg R, Kan JP, Michaud JC, Bourguignon JJ, Wermuth CG, Feltz P, Worms P, Biziere K.
    Eur J Pharmacol; 1989 Jul 18; 166(2):139-47. PubMed ID: 2792188
    [Abstract] [Full Text] [Related]

  • 3. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM, Bolliger G, Closse A, Enz A, Gmelin G, Malanowski J.
    Eur J Pharmacol; 1986 Jun 05; 125(1):45-62. PubMed ID: 3732391
    [Abstract] [Full Text] [Related]

  • 4. SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.
    Kan JP, Steinberg R, Oury-Donat F, Michaud JC, Thurneyssen O, Terranova JP, Gueudet C, Souilhac J, Brodin R, Boigegrain R.
    Psychopharmacology (Berl); 1993 Jun 05; 112(2-3):219-27. PubMed ID: 7871023
    [Abstract] [Full Text] [Related]

  • 5. Aminopyridazines--an alternative route to potent muscarinic agonists with no cholinergic syndrome.
    Wermuth CG.
    Farmaco; 1993 Feb 05; 48(2):253-74. PubMed ID: 8494598
    [Abstract] [Full Text] [Related]

  • 6. Cholinomimetic activity of minaprine is related to the amelioration of delayed neuronal death in gerbils.
    Karasawa Y, Araki H, Otomo S.
    Physiol Behav; 1992 Jul 05; 52(1):141-7. PubMed ID: 1528997
    [Abstract] [Full Text] [Related]

  • 7. Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice.
    Worms P, Biziere K.
    Psychopharmacology (Berl); 1987 Jul 05; 93(4):489-93. PubMed ID: 2893415
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.
    Bizière K, Kan JP, Souilhac J, Muyard JP, Roncucci R.
    Arzneimittelforschung; 1982 Jul 05; 32(8):824-31. PubMed ID: 6890359
    [Abstract] [Full Text] [Related]

  • 9. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E.
    J Pharmacol Exp Ther; 1991 Apr 05; 257(1):392-403. PubMed ID: 2019998
    [Abstract] [Full Text] [Related]

  • 10. Effect of minaprine on cycloheximide-induced amnesia in mice.
    Nabeshima T, Kawashima K, Kameyama T.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):249-57. PubMed ID: 2530096
    [Abstract] [Full Text] [Related]

  • 11. Alterations of serotonin neurotransmission and inhibition of mouse-killing behavior: III. Effects of minaprine, CM 30366 and SR 95191.
    Isel F, Mandel P.
    Pharmacol Biochem Behav; 1989 Jul 10; 33(3):655-62. PubMed ID: 2531423
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639.
    Boast CA, Leventer S, Sabb A, Abelson M, Bender R, Giacomo D, Maurer S, McArthur S, Mehta O, Morris H.
    Pharmacol Biochem Behav; 1991 Jun 10; 39(2):287-92. PubMed ID: 1658814
    [Abstract] [Full Text] [Related]

  • 13. Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.
    Worms P, Gueudet C, Pério A, Soubrié P.
    Psychopharmacology (Berl); 1989 Jun 10; 98(2):286-8. PubMed ID: 2502800
    [Abstract] [Full Text] [Related]

  • 14. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J, Lembøl HL, Meier E, Pedersen H.
    Eur J Pharmacol; 1992 Jul 21; 218(1):159-69. PubMed ID: 1397027
    [Abstract] [Full Text] [Related]

  • 15. Minaprine, a new drug with antidepressant properties.
    Bizière K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R.
    Drugs Exp Clin Res; 1985 Jul 21; 11(12):831-40. PubMed ID: 3836113
    [Abstract] [Full Text] [Related]

  • 16. Central cholinergic agents. III. Synthesis of 2-alkoxy-2,8- diazaspiro[4.5]decane-1,3-diones as muscarinic agonists.
    Ishihara Y, Yukimasa H, Miyamoto M, Goto G.
    Chem Pharm Bull (Tokyo); 1992 May 21; 40(5):1177-85. PubMed ID: 1394631
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus properties of physostigmine in rats.
    Tang AH, Franklin SR.
    Eur J Pharmacol; 1988 Aug 09; 153(1):97-104. PubMed ID: 3215280
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of the active site of minaprine from that of phencyclidine in rat hippocampus.
    Chaki S, Usuki-Ito C, Muramatsu M, Otomo S.
    Res Commun Chem Pathol Pharmacol; 1990 Jul 09; 69(1):85-98. PubMed ID: 1977191
    [Abstract] [Full Text] [Related]

  • 19. Minaprine cancels scopolamine effects on the rat's acquisition of passive avoidance responses in two multitrial paradigms.
    Ambrogi Lorenzini C, Baldi E, Bucherelli C, Tassoni G.
    Pharmacol Biochem Behav; 1992 Apr 09; 41(4):715-8. PubMed ID: 1594638
    [Abstract] [Full Text] [Related]

  • 20. Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
    Yamamoto T, Yatsugi S, Ohno M, Furuya Y, Kitajima I, Ueki S.
    Psychopharmacology (Berl); 1990 Apr 09; 100(3):316-22. PubMed ID: 2315427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.